?
Optimal dosing**: What level of kinase inhibition is needed vs. tolerated?
active
open question
Created: 2026-04-25T20:29:35
By: backfill_open_questions
Quality:
50%
✓ SciDEX
ID: open_question-6a9df73d-c9ce-4987-ba6a-7a
Open Question
open
Wiki: mechanisms-lrrk2-kinase-pathway-parkinsons
Optimal dosing**: What level of kinase inhibition is needed vs. tolerated?
Importance Elo
1500
Field Rank
Rank #1150 in mechanisms
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page mechanisms-lrrk2-kinase-pathway-parkinsons
Secondary Market
No secondary market activity yet. Learn about share issuance →
Share Holder Leaderboard
No shares issued yet.
Evidence Bearing On This Question
AMPK hypersensitivity in astrocytes creates enhanced mitochondrial rescue responses
candidate answer · hypothesis · 80%
Serine/Arginine-Rich Protein Kinase Modulation
candidate answer · hypothesis · 75%
mTOR inhibitor validation experiment
partial answer for · experiment · 72%
Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown
partial answer for · experiment · 68%
Enzymatic Pathway Investigation Using Inhibitors and KO Mice
discriminating experiment · experiment · 60%
AAV-LRRK2 IND-Enabling Study Design
bears on question · experiment · 55%
PFF uptake in primary hippocampal neurons with inhibitors
partial answer for · experiment · 55%
Glycine-Rich Domain Competitive Inhibition
partial answer for · hypothesis · 55%
PARP1 Inhibition Therapy
partial answer for · hypothesis · 50%
AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Therapy
bears on question · experiment · 50%
PFF clearance kinetics in Snca knockout mice
bears on question · experiment · 40%
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
AMPK hypersensitivity in astrocytes creates enhanced mitochondrial rescue responses
hypothesis | candidate_answer
Serine/Arginine-Rich Protein Kinase Modulation
hypothesis | candidate_answer
Glycine-Rich Domain Competitive Inhibition
hypothesis | partial_answer_for
PARP1 Inhibition Therapy
hypothesis | partial_answer_for
Related Entities
▸Metadata
| status | open |
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-26T03:29:35.365580'} |
| field_tag | mechanisms |
| source_id | mechanisms-lrrk2-kinase-pathway-parkinsons |
| sub_field | lrrk2-kinase-pathway-parkinsons |
| source_kind | wiki |
| question_hash | 6045a8b1c00f534fb29291be0ab691c988ef5bbb8296d82bfd8c42e448f1cc4a |
| question_text | Optimal dosing**: What level of kinase inhibition is needed vs. tolerated? |
| importance_elo | 1500 |
| _schema_version | 1 |
| evidence_summary | Extracted from wiki page mechanisms-lrrk2-kinase-pathway-parkinsons |
| evidence_xref_at | 2026-04-27T13:27:33.952969+00:00 |
| tractability_score | 0.5 |
| potential_impact_score | 0.5 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
12
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.